# Phase 2 Bronchiolitis Obliterans Syndrome trials: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in phase 2 for Bronchiolitis Obliterans Syndrome that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Bronchiolitis Obliterans Syndrome trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/bronchiolitis-obliterans-syndrome

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 18, 2026 | NCT07771855 | Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in... | Hopital Foch | Phase 2 | Recruiting | Bronchiolitis Obliterans Syndrome (BOS), HSCT, Bronchial Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771855) |
| June 5, 2026 | NCT07630727 | Study of AHB-171 in Chronic Hepatitis B Participants | Ausper Biopharma Co., Ltd. | Phase 2 | Recruiting | Hepatitis B, Chronic (CHB) | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630727) |
| May 26, 2026 | NCT07606703 | A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT | Sponsor not shown (see the record) | Phase 2 | Recruiting | Chronic Graft-Versus-Host Disease, Graft vs Host Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606703) |
| January 21, 2026 | NCT07354074 | Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP | Novartis Pharmaceuticals | Phase 2 | Recruiting | Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354074) |
| August 15, 2025 | NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at... | Incyte Corporation | Phase 2 | Recruiting | Chronic Graft-versus-host-disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07124078) |
| August 11, 2025 | NCT07116031 | A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) | Sanofi | Phase 2 | Recruiting | Chronic Graft Versus Host Disease | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07116031) |
| June 10, 2025 | NCT07011810 | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Fred Hutchinson Cancer Center | Phase 2 | Recruiting | Chronic Graft Versus Host Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07011810) |
| March 27, 2025 | NCT06897605 | Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients | Mansoura University | Phase 2 | Recruiting | Chronic Kidney Disease(CKD), Anemia, Kidney Disease, Chronic | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06897605) |
| December 31, 2024 | NCT06752720 | Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients | Hokkaido University Hospital | Phase 2 | Recruiting | Stroke, Stroke, Ischemic, Stroke; Sequelae | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06752720) |
| October 29, 2024 | NCT06663722 | Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease | University of Miami | Phase 2 | Recruiting | Chronic Graft Versus Host Disease, cGVHD | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06663722) |
| October 28, 2024 | NCT06660355 | Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 | Recruiting | Chronic Graft-versus-host Disease (cGVHD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06660355) |
| October 1, 2024 | NCT06619561 | A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) | Deciphera Pharmaceuticals, LLC | Phase 2 | Recruiting | Chronic Graft-Versus-Host Disease (cGVHD) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06619561) |
| May 17, 2024 | NCT06419439 | Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression | VA Office of Research and Development | Phase 2 | Recruiting | Chronic Low Back Pain, Depression | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06419439) |
| March 8, 2024 | NCT06300320 | A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 | Recruiting | Chronic Graft Versus Host Disease | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06300320) |
| August 31, 2023 | NCT06018766 | LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. | Sponsor not shown (see the record) | Phase 2 | Recruiting | Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction, Lung Transplantation | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06018766) |
| August 18, 2023 | NCT05996627 | Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease | Fred Hutchinson Cancer Center | Phase 2 | Recruiting | Chronic Graft Versus Host Disease | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05996627) |
| July 19, 2023 | NCT05951777 | Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury | Hope Biosciences LLC | Phase 2 | Recruiting | Traumatic Brain Injury | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05951777) |
| June 28, 2023 | NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | Dana-Farber Cancer Institute | Phase 2 | Recruiting | Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases, Chronic Graft Versus Host Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05922761) |
| October 18, 2022 | NCT05584124 | Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue | VA Office of Research and Development | Phase 2 | Recruiting | Stroke, Stroke, Chronic, Fatigue | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05584124) |
| January 14, 2021 | NCT04710576 | A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) | Syndax Pharmaceuticals | Phase 2 | Recruiting | Chronic Graft-versus-host-disease | 296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04710576) |
| September 28, 2016 | NCT02918188 | Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD | Navy General Hospital, Beijing | Phase 2 | Recruiting | Chronic Graft-versus-host Disease | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02918188) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| VA Office of Research and Development | 2 |
| Fred Hutchinson Cancer Center | 2 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 1 |
| Dana-Farber Cancer Institute | 1 |
| Hokkaido University Hospital | 1 |
| Hope Biosciences LLC | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Navy General Hospital, Beijing | 1 |
| Hopital Foch | 1 |
| [Chia Tai Tianqing Pharmaceutical Group Co., Ltd.](https://specstream.ai/data/clinical-trials/company/chia-tai-tianqing-pharmaceutical-group-co-ltd) | 1 |
| Mansoura University | 1 |
| University of Miami | 1 |
| Ausper Biopharma Co., Ltd. | 1 |
| [Deciphera Pharmaceuticals, LLC](https://specstream.ai/data/clinical-trials/company/deciphera-pharmaceuticals-llc) | 1 |
| [Syndax Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/syndax-pharmaceuticals) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 14 |
| China | 6 |
| France | 4 |
| Germany | 4 |
| Italy | 4 |
| Spain | 4 |
| Belgium | 3 |
| Canada | 3 |
| Japan | 3 |
| United Kingdom | 3 |
| Israel | 2 |
| Netherlands | 2 |
| Australia | 2 |
| Poland | 2 |
| Singapore | 2 |
| South Korea | 2 |
| Turkey (Türkiye) | 1 |
| Brazil | 1 |
| Hungary | 1 |
| Thailand | 1 |
| Vietnam | 1 |
| Egypt | 1 |
| Greece | 1 |
| Portugal | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B background check companies in the United States](https://specstream.ai/data/businesses/b2b-background-check-companies/united-states)
- [Collection agencies in the United States](https://specstream.ai/data/businesses/collection-agencies/united-states)
- [Filipino restaurants in the United States](https://specstream.ai/data/businesses/filipino-restaurants/united-states)
- [Italian restaurants in the United States](https://specstream.ai/data/businesses/italian-restaurants/united-states)
- [Paving contractors in the United States](https://specstream.ai/data/businesses/paving-contractors/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
